CG Oncology, Inc.

SecurityCGON / CG Oncology, Inc.
InsiderHong Fang Song
This page shows the track record and history of Song Hong Fang insider trades in CG Oncology, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Hong Fang Song in CGON / CG Oncology, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2024-01-29 263,157 19.0000 263,157 19.0000 4,999,983 18 47.9300 7,613,132 152.26

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CGON / CG Oncology, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Hong Fang Song in CGON / CG Oncology, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-09-03 69,695 27.6000 69,695 27.6000 1,923,582 0 28.6700 74,574 3.88
2025-09-03 30,105 28.2400 30,105 28.2400 850,165
2025-09-03 100 28.9600 100 28.9600 2,896
2025-09-03 100 28.9900 100 28.9900 2,899
2024-12-16 700,000 28.0000 700,000 28.0000 19,600,000
2024-08-29 424,210 35.3600 424,210 35.3600 15,000,066
2024-08-29 226,245 35.3600 226,245 35.3600 8,000,023

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CGON / CG Oncology, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-09-04 2025-09-03 4 Song Hong Fang By Charming Jade Limited CGON Common Stock S - Sale I 28.9900 -100 -3 2,903,931
2025-09-04 2025-09-03 4 Song Hong Fang By Charming Jade Limited CGON Common Stock S - Sale I 28.9600 -100 -3 2,904,031
2025-09-04 2025-09-03 4 Song Hong Fang By Charming Jade Limited CGON Common Stock S - Sale I 28.2400 -30,105 -850 2,904,131
2025-09-04 2025-09-03 4 Song Hong Fang By Chaming Jade Limited CGON Common Stock S - Sale I 27.6000 -69,695 -1,924 2,934,236
2024-12-17 2024-12-16 4 Song Hong Fang By Charming Jade Limited CGON Common Stock S - Sale I 28.0000 -700,000 -19,600 3,003,931
2024-08-30 2024-08-29 4 Song Hong Fang By Charming Jade Limited CGON Common Stock S - Sale I 35.3600 -226,245 -8,000 3,703,931
2024-08-30 2024-08-29 4 Song Hong Fang By Unique Diamond Investments Limited CGON Common Stock S - Sale I 35.3600 -424,210 -15,000 586,982
2024-01-31 2024-01-29 4 Song Hong Fang CGON Common Stock P - Purchase D 19.0000 263,157 5,000 613,928
2024-01-31 2024-01-29 4 Song Hong Fang By Charming Jade Limited CGON Common Stock C - Conversion I 3,930,176 3,930,176
2024-01-31 2024-01-29 4 Song Hong Fang By Unique Diamond Investments Limited CGON Common Stock C - Conversion I 1,011,192 1,011,192
2024-01-31 2024-01-29 4 Song Hong Fang CGON Common Stock C - Conversion D 350,771 350,771
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)